IP Verse

Management Of Breakthrough Bleeding In Extended Hormonal Contraceptive Regimens - EP1747001

The patent EP1747001 was granted to Bayer on Oct 10, 2018. The application was originally filed on Apr 29, 2005 under application number EP05740127A. The patent is currently recorded with a legal status of "Revoked".

EP1747001

BAYER
Application Number
EP05740127A
Filing Date
Apr 29, 2005
Status
Revoked
Sep 16, 2024
Grant Date
Oct 10, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBJul 10, 2019TER MEER STEINMEISTER & PARTNER -
DR SCHONNov 16, 2018SCHONADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONUSRE37564E
INTERNATIONAL-SEARCH-REPORTEP0911029
INTERNATIONAL-SEARCH-REPORTUS2003119798
INTERNATIONAL-SEARCH-REPORTUS6451778
INTERNATIONAL-SEARCH-REPORTUS6500814
INTERNATIONAL-SEARCH-REPORTUSRE37838E
INTERNATIONAL-SEARCH-REPORTWO0222110
INTERNATIONAL-SEARCH-REPORTWO9804269
OPPOSITIONUS5898032
OPPOSITIONUSRE37564E
OPPOSITIONWO0222110
OPPOSITIONWO2005105103
OPPOSITIONWO9804269
OTHERUSRE37564E

Non-Patent Literature (NPL) Citations (23) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- KLIPPING C ET AL, "Contraceptive efficacy and tolerability of ethinylestradiol 20 [mu]g/drospirenone 3 mg in a flexible extended regimen: An open-label, multicentre, randomised, controlled study", JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE 2012 ROYAL COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS GBR, (201204), vol. 38, no. 2, ISSN 1471-1893, pages 73 - 83-
EXAMINATION- Szarewski A. and Guillebaud J, Contraception: A User's Handbook, Oxford University Press, (2000), pages 73 - 89-
INTERNATIONAL-SEARCH-REPORT- BIRKHAEUSER M ET AL, "EMPFEHLUNGEN ZUR HORMONALEN KONTRAZEPTION", FRAUENARZT, PUBLIMED, MED. U. MEDIEN DEUTSCHE GESELLSCHAFT FüR GYNäKOLOGIE, DE, (2003), vol. 44, no. 12, ISSN 0016-0237, pages 1270 - 1273, XP009055739 [Y] 1-7,9-16,19-49,53,56-60,62-69 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- JENAPHARM, "NEUES PERIODENSYSTEM MIT VALETTE", JENAPHARM, (200403), XP002350231 [X] 1-4,6,7,14-16,19-22,25-41,53,56,57,59,60,67-69 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- ROSENBERG ET AL, "Causes and consequences of oral contraceptive noncompliance", AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY, MOSBY, ST LOUIS, MO, US, (199902), vol. 180, no. 2, ISSN 0002-9378, pages S276 - S279, XP005179066 [Y] 1-7,9-16,19-49,53,56-60,62-69 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- SILLEM M ET AL, "Use of an oral contraceptive containing drospirenone in an extended regimen.", THE EUROPEAN JOURNAL OF CONTRACEPTION & REPRODUCTIVE HEALTH CARE : THE OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY OF CONTRACEPTION. SEP 2003, (200309), vol. 8, no. 3, ISSN 1362-5187, pages 162 - 169, XP008064769 [Y] 1-4,6,7,11-13,19,40-42,44,53,56,57,59,64-66 * abstract * * page 163, paragraph 3 * * page 165, paragraphs 1,2 * * page 167, column 2, paragraph 3 - page 168, column 2, paragraph 2 *-
INTERNATIONAL-SEARCH-REPORT- WIEGRATZ I ET AL, "Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives", CONTRACEPTION, GERON-X, INC., LOS ALTOS, CA, US, (200401), vol. 69, no. 1, ISSN 0010-7824, pages 37 - 42, XP002353728 [Y] 1-7,9-16,19-49,53,56-60,62-69 * the whole document *
OPPOSITION- anonymous, "Many Women Taking Low-Dose Oral Contraceptives Choosing to Eliminate Monthly Periods", Women's Health Update, (20000900), XP055624659-
OPPOSITION- Anonymous, "SEC Report of Schering AG", UNITED STATES SECURITIES AND EXCHANGE COMMISSION, (20050318), URL: https://www.sec.gov/Archives/edgar/data/1124139/000116854805000033/sag20-f2004.htm, XP055624693-
OPPOSITION- "PRACTICAL ASPECTS OF TAKING THE COMBINED PILL", SZAREWSKI A. et al., Contraception: A User's Handbook, (20000000), pages 73 - 89, XP003033293-
OPPOSITION- SILLEM M. et al., "Use of an oral contraceptive containing drospirenone in an extended regimen", The European Journal of Contraception and Reproductive Health Care, (20030900), vol. 8, no. 3, pages 162 - 169, XP008064769-
OPPOSITION- SULAK PATRICIA J., "Contraceptive redesign: new progestins/new regimens", Journal of Family Practice, (20040901), vol. 53, no. 9, page SS3, XP055624663-
OPPOSITION- SULAK PATRICIA J., "Cover Story: Should your patients be on extended-use OCs?", Contemporary Ob/Gyn, (20030901), URL: https://www.contemporaryobgyn.net/article/cover-story-should-your-patients-be-extended-use-ocs, XP055624682-
OPPOSITION- SULAK PATRICIA J., "Using Contraceptives to alter bleeding patterns", OBG Management, (20030300), vol. 15, no. 3, pages 34 - 45, XP055624667-
OPPOSITION- M. J. ROSENBERG et al., "Oral contraceptives and cycle control: A critical review of the literature", Advances in Contraception, (19921000), vol. 8, no. S1, pages 35 - 45, XP055624655
OPPOSITION- P. SULAK et al., "Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding", Contraception, (20040000), vol. 70, doi:10.1016/j.contraception.2004.04.007, pages 281 - 287, XP004580051
OPPOSITION- P. SULAK et al., "Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding", Contraception, (20040000), vol. 70, pages 281 - 287, XP004580051
OPPOSITION- G. BACHMANN et al., "Efficacy and safety of a low dose 24-day combined oral contraceptive containing 20 µg ethinylestradiol and 3 mg drospirenone", Contraception, (20040000), vol. 70, doi:10.1016/j.contraception.2004.05.013, pages 191 - 198, XP004533144
OPPOSITION- G. BACHMANN et al., "Efficacy and safety of a low dose 24-day combined oral contra- ceptive containing 20 µg ethinylestradiol and 3 mg drospirenone", Contraception, (20040000), vol. 70, pages 191 - 198, XP004533144
OPPOSITION- KLIPPING et al., "Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism", Contraception, (20050600), vol. 71, no. 6, pages 409 - 416, XP027650388
OPPOSITION- KLIPPING C. et al., "Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study", J. Fam. Plann. Reprod. Health Care, (20120400), vol. 38, no. 2, pages 73 - 83, XP055624677
OPPOSITION- W. OELKERS et al., "Effects of a New Oral Contraceptive Containing an Antimineralocorticoid Progestogen, Drospirenone, on the Renin Aldosterone System, Body Weight, Blood Pressure, Glucose Tolerance, and Lipid Metabolism", Journal of Clinical Endocrinology and Metabolism, (19950000), vol. 80, no. 6, doi:10.1210/jc.80.6.1816, pages 1816 - 1821, XP002046682
OTHER- "PRACTICAL ASPECTS OF TAKING THE COMBINED PILL", SZAREWSKI A. ET AL, CONTRACEPTION: A USER'S HANDBOOK., OXFORT UNIVERSITY PRESSW, (2000), pages 73 - 89, XP003033293-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents